Publications

1. Houwink E, Meagher KM, Thorsteindottir B, Agam P, Kaam O, Anderson JL, Bidwell J, Cobran EK, Dugani SB, Dupras D, Kemppainen JL, Kullo IJ, Presutti RJ, Pruthi S, Salter TG, Takahashi PY. Ethically integrating genomics in primary care: An invitation to share implementation best practices. Mayo Clinic Proceedings. 2025; (In Press).
   
2. Cromer SJ, Cobran EK, Iyer HS, Hysong MR, Vargas LB, Smith JL, Konigsberg IR, Bogumil D, Gloer L, King G, Polygenic Risk Methods Development Consortium SDoH Working Group, Lange L, Patel A, Wojcik G, Raffield L, Conti DV. Incorporating polygenic risk scores and social detriments of health across populations: Considerations and best practices in research. American Journal of Human Genetics. 2025; (In Press).
   
3. Smith JL, Adebamowo CA, Adebamowo SN, Darst BF, Fullerton M, Gogarten SM, Hamed ME, Hirbo JB, Hysong MR, Johar AS, Khan AT, Kullo IJ, Koigsberg IR, Kraft P, Lange LA, Li Y, Martin AR, Nelson SC, Choudhury A, Ramsay M, Cobran EK, Schaid DL, Sharma J, Wang Y, Wojcik GL, Polygenic Risk Methods in Diverse Populations (PRIMED) Consortium, Quan S. Recommendations for responsible use of population descriptors in polygenic risk score development. Nature Genetics. 2025; (In Press).
   
4. Ashing K, Willis F, Williams C, Morrison J, McCall J, Song G, Bedell F, Moore C, Cobran EK, Ngufor C, Bonner T, Dagne G, Merriweather A, Oliver J, Kaninjing E, Oladapo R, Dronca R, Odedina F. Development of a prostate cancer survivorship care plan with clinical and contextual tailoring Supportive Care in Cancer. 2025; (In Press).
   
5. Asiri IM, Chen RC, Master V, Mi L, James SE, Moore C, Bryce AH, Tilburt JC, Riaz IB, Naqui S, Afzal U, Beack S, Cobran EK. Mortality in castration resistant prostate cancer patient with and without pre-existing cardiovascular disease receiving oral androgen receptor pathway inhibitors Pharmacoepidemiology and Drug Safety. 2025; (In Press).
   
6. Storandt MH, Jin Z, Ruddy KJ, Pachman DR, Kour O, Grzegorczyk V, Kroenke K, Griffin JM, Austin JD, Mitchell SA, Smith AW, Ehlers S, Chlan LL, Cobran EK, Greenmyer JR, Allen-Rhoades WA, Shi Q, Cheville AL. Symptom Burden in Adolescents and Young Adults With Cancer. JAMA Netw Open. 2025 Aug 1; 8 (8):e2527421 Epub 2025 Aug 01
   View PubMed
7. Asiri IM, Chen RC, Master V, Mi L, James SE, Bryce AH, Afzal U, Riaz IB, Ahmed Naqvi SA, Beach SRH, Cobran EK. Thromboembolic Events in Castration-Resistant Prostate Cancer Patients With and Without Cardiovascular Comorbidities Receiving Oral Androgen Receptor Pathway Inhibitors. Prostate. 2025 Jul; 85 (10):954-965 Epub 2025 May 01
   View PubMed
8. Naqvi SAA, Riaz IB, Bibi A, Khan MA, Imran M, Khakwani KZR, Raina A, Anjum MU, Cobran EK, Warner JL, Hussain SA, Singh P, Childs DS, Baca SC, Orme JJ, Mateo J, Agarwal N, Gillessen S, Murad MH, Sartor O, Bryce AH. Heterogeneity of the Treatment Effect with PARP Inhibitors in Metastatic Castration-resistant Prostate Cancer: A Living Interactive Systematic Review and Meta-analysis. Eur Urol. 2025 Jun; 87 (6):626-640 Epub 2025 Jan 23
   View PubMed
9. Asiri IM, Chen RC, Master V, Mi L, James SE, Odedina FT, Bryce AH, Tilburt JC, Riaz IB, Naqvi SAA, Abraham V, Beach SRH, Cobran EK. Treatment switching between Enzalutamide and Abiraterone Acetate and time to oral opioid initiation in castration-resistant prostate cancer patients. Cancer Epidemiol. 2025 Apr; 95:102769 Epub 2025 Feb 12
   View PubMed
10. Yap JQ, Riggan KA, Cobran EK, Halyard MY, James SE, Kelly MK, Phillips DT, Allyse MA. Psychological Safety in the Medical Care of Black Breast and Ovarian Cancer Patients and Families. Psychooncology. 2025 Mar; 34 (3):e70127
    View PubMed
11. James SE, Riggan KA, Halyard M, Kelly M, Cobran E, Allyse MA. The "Strong Black Woman" Paradox: Insights from a Cohort of Black Breast and Ovarian Cancer Patients and Family Members. J Racial Ethn Health Disparities. 2025 Feb; 12 (1):659-665 Epub 2024 Jan 08
    View PubMed
12. Schaid DJ, McDonnell SK, Akhtari FS, Sinnwell JP, Batzler A, Cobran EK, Motsinger-Reif A. Polygenic scores and social determinants of health: Their correlations and potential biases. HGG Adv. 2025 Jan 9; 6 (1):100389 Epub 2024 Nov 27
    View PubMed
13. Bryant AL, Krok-Schoen JL, Cobran EK, Greer JA, Temel JS, Pirl WF. Evaluation of an intensive workshop on research methods in supportive oncology. Palliat Support Care. 2024 Aug; 22 (4):649-654
    View PubMed
14. Ali AM, Cobran EK, Young HN. Individual, interpersonal, and community factors associated with health outcomes in patients with type 2 diabetes mellitus treated at federally qualified health centers. J Diabetes Metab Disord. 2024 Jun; 23 (1):1071-1080 Epub 2024 Feb 14
    View PubMed
15. Rawal S, Osae SP, Cobran EK, Albert A, Young HN. Pharmacists' naloxone services beyond community pharmacy settings: A systematic review. Res Social Adm Pharm. 2023 Feb; 19 (2):243-265 Epub 2022 Sept 15
    View PubMed
16. Asiri IM, Chen RC, Young HN, Codling J, Mandawat A, Beach SRH, Master V, Rajbhandari-Thapa J, Cobran EK. Race and prostate specific antigen surveillance testing and monitoring 5-years after definitive therapy for localized prostate cancer. Prostate Cancer Prostatic Dis. 2021 Dec; 24 (4):1093-1102 Epub 2021 May 03
    View PubMed
17. Montiel Ishino FA, Rowan C, Das R, Thapa J, Cobran E, Whiteside M, Williams F. Identifying Risk Profiles of Malignant Prostate Cancer Surgical Delay Using a Person-Centered Approach to Understand Prostate Cancer Disparities: The Constellation of Health Determinants Using Latent Class Analysis on Cancer Registry Data. Am J Mens Health. 2020 Nov-Dec; 14 (6):1557988320984282
    View PubMed
18. Cobran EK, Young HN, Chen RC, Chen X, Reeves J, Godley PA, Shah S. Race and Timing of Androgen Deprivation Therapy among Men with Metastatic Prostate Cancer. Journal of the National Medical Association. 2019; S0027-9684(18):30168-8.
    
19. Alwhaibi A, Kolhe R, Gao F, Cobran EK, Somanath PR. Genome Atlas Analysis based Profiling of Akt Pathway Genes in the Early and Advanced Human Prostate Cancer. Oncoscience. 2019; 6(5-6):317-36.
    
20. Shah S, Young HN, Cobran EK. Comparative Effectiveness of Conservative Management Compared to Cryotherapy in Localized Prostate Cancer Patients. Am J Mens Health. 2018 Sep; 12 (5):1681-1691 Epub 2018 June 07
    View PubMed
21. Shah S, Cobran EK, Young H. An Economic Evaluation of Conservative Management and Cryotherapy in Patients with Localized Prostate Cancer. Journal of Pharmaceutical Health Services Research. 2018.
    
22. Cobran EK, Hall JN, & Aiken W. African-American and Caribbean-born men’s perceptions of prostate cancer fear and facilitators for screening behavior: A pilot study. Journal of Cancer Education. 2017.
    
23. Shah S, Wei H, Jayawardhana J, Perri M, Cobran EK, Young H. Cost utility analysis of Methylphenidate and Amphetamine/Dexamphetamine in adults with Attention-deficit hyperactivity disorder. Journal of Pharmaceutical Health Services Research. 2017.
    
24. Cobran EK, Merino Y, Roach B, Bigelow SM, Godley PA. A feasibility study of the independent specialty medical advocate model of patient navigation on intermediate health outcomes in newly diagnosed cancer patients. Journal of Oncology Navigation & Survivorship. 2017; 8(10):462-70.
    
25. Cobran EK, Chen RC, Overman R, Meyer AM, Kuo TM, O'Brien J, Sturmer T, Sheets NC, Goldin GH, Penn DC, Godley PA, Carpenter WR. Racial Differences in Diffusion of Intensity-Modulated Radiation Therapy for Localized Prostate Cancer. Am J Mens Health. 2016 Sep; 10 (5):399-407 Epub 2015 Feb 05
    View PubMed
26. Pen D, Stitzenberg K, Cobran EK, Godley PA. Provider-based Research Network Demonstrate Greater Hospice Use for Minority Patients with Lung Cancer J Oncol Pract. 2014; 10(4):182-90.
    
27. Cobran EK, Wutoh AK, Lee E, Odedina F, Ragin C, Aiken W, Godley P. Perceptions of Prostate Cancer Fatalism and Screening Behavior Between United States-born and Caribbean-born Black Males J Immigr Minor Health. 2014; 16(3):394-400.
    
28. Wutoh AK, Nichols-English G, Daniel M, Kendall KA, Cobran EK, et al. Pilot Study to Assess HIV Knowledge Spirituality, and Risk Behaviors Among Older African Americans J Natl Med Assoc. 2011; 103:265-8.